ArticleThe AAPS journal2026

Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products.

Jennifer K Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.